NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

Gary,

Appreciate your perspective!

How much money in total do you think NWBO used in the last 10-12 years for DCVAX-L and Direct trials? There is no guarantee that we won’t go through the same challenges and journey again even if we receive $1 or 2B in cash injection via partnership. There is still a ton of work on the Direct side to understand optimal dosage, delivery mechanism, efficacy, etc. Its another 10 year journey, for sure. How old will the current management be? Believe me, NWBO management team would want a buyout regardless of what your hear them say in public domain! ;)

I personally believe Merck is the best company to get a deal done (provided they value NWBO fairly). They have a leadership position in oncology. They have appropriate experience, network, team to fast track future oncology trials. Also, when you spend in excess of $20B for an acquisition, you’re not thinking about necessarily delaying the introduction of a new technology even if it undercuts some of their legacy business(es). You work towards creating additive value, and think of it as complementary rather than competitive product. By the way, which of Merck’s product will DCVAX-L replace and when?

Anyway, I am with you we will have publication this quarter, in which case I will hold on for another year to see how they approach various RAs and go to market strategy. If my intuition is right, we will see a buyout before that!